Redx Pharma PLC
LSE:REDX
Redx Pharma PLC
Interest Income Expense
Redx Pharma PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
R
|
Redx Pharma PLC
LSE:REDX
|
Interest Income Expense
£585k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
89%
|
CAGR 10-Years
N/A
|
GlaxoSmithKline PLC
LSE:GSK
|
Interest Income Expense
-£641m
|
CAGR 3-Years
8%
|
CAGR 5-Years
1%
|
CAGR 10-Years
0%
|
|
AstraZeneca PLC
LSE:AZN
|
Interest Income Expense
-$1.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-12%
|
|
Indivior PLC
LSE:INDV
|
Interest Income Expense
$9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Interest Income Expense
-$67m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-6%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Interest Income Expense
-£21m
|
CAGR 3-Years
-34%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-14%
|
See Also
What is Redx Pharma PLC's Interest Income Expense?
Interest Income Expense
585k
GBP
Based on the financial report for Sep 30, 2023, Redx Pharma PLC's Interest Income Expense amounts to 585k GBP.
What is Redx Pharma PLC's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
89%
Over the last year, the Interest Income Expense growth was -23%.